Smith & Nephew Pays $782M For Texas Wound Care Co.
The acquisition gives London-based Smith & Nephew a foothold in the fast-growing bioactive wound healing market, a $1 billion submarket of the advanced wound care industry. Healthpoint is projected to have 2012 revenues of $190 million and manufactures the popular treatment Santyl, a bioactive ointment for the removal of dead tissue in wounds.
Smith & Nephew will fund the...
To view the full article, register now.